HK1027508A1 - Composition for prevention of hepatic steatosis. - Google Patents

Composition for prevention of hepatic steatosis.

Info

Publication number
HK1027508A1
HK1027508A1 HK00106722A HK00106722A HK1027508A1 HK 1027508 A1 HK1027508 A1 HK 1027508A1 HK 00106722 A HK00106722 A HK 00106722A HK 00106722 A HK00106722 A HK 00106722A HK 1027508 A1 HK1027508 A1 HK 1027508A1
Authority
HK
Hong Kong
Prior art keywords
prevention
composition
hepatic steatosis
steatosis
hepatic
Prior art date
Application number
HK00106722A
Inventor
Yun K Tam
Nuzhar Zaman
Naobumi Ishida
Original Assignee
Yun K Tam
Zaman Nuzhat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yun K Tam, Zaman Nuzhat filed Critical Yun K Tam
Publication of HK1027508A1 publication Critical patent/HK1027508A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
HK00106722A 1997-03-17 2000-10-23 Composition for prevention of hepatic steatosis. HK1027508A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA1997/000176 WO1998041216A1 (en) 1997-03-17 1997-03-17 Composition for prevention of hepatic steatosis

Publications (1)

Publication Number Publication Date
HK1027508A1 true HK1027508A1 (en) 2001-01-19

Family

ID=4173204

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00106722A HK1027508A1 (en) 1997-03-17 2000-10-23 Composition for prevention of hepatic steatosis.

Country Status (4)

Country Link
JP (1) JP2001514667A (en)
AU (1) AU2089297A (en)
HK (1) HK1027508A1 (en)
WO (1) WO1998041216A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1749539A2 (en) * 2000-08-01 2007-02-07 Shionogi Co., Ltd. Preventives or remedies for fatty liver
DE10057290B4 (en) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral supplement for parenteral nutrition or partial enteral / oral nutrition for critically ill, chronically ill and malnourished
US6596762B2 (en) 2001-05-17 2003-07-22 The Regents Of The University Of Colorado Antioxidant compositions and use for treatment of hepatic steatosis and steatohepatitis
WO2005051298A2 (en) 2003-11-19 2005-06-09 Metabasis Therapeutics, Inc. Novel phosphorus-containing thyromimetics
CA2606499C (en) 2005-05-26 2017-06-13 Metabasis Therapeutics, Inc. Thyromimetics for the treatment of fatty liver diseases
CN102215836B (en) * 2008-09-19 2015-07-08 雀巢产品技术援助有限公司 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment
KR20190104524A (en) 2016-11-21 2019-09-10 바이킹 테라퓨틱스 인코포레이티드 Treatment method of sugar accumulation disease
CZ201740A3 (en) * 2017-01-26 2018-08-08 Vidia spol. s r.o. Use of a preparation for peroral administration containing lignin
KR102600115B1 (en) 2017-06-05 2023-11-09 바이킹 테라퓨틱스 인코포레이티드 Composition for treating fibrosis
EP3768690A4 (en) 2018-03-22 2021-11-24 Viking Therapeutics, Inc. Crystalline forms and methods of producing crystalline forms of a compound
CN114146184A (en) * 2021-12-03 2022-03-08 成都施桂行医药科技有限责任公司 Use of cationic polymers for the preparation of medicaments

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB931921A (en) * 1960-12-22 1963-07-24 Lab Roques Therapeutic compositions intended for the treatment of any hepatic malfunctionings
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
GB9026648D0 (en) * 1990-12-07 1991-01-23 Efamol Holdings Nutrition
WO1995018608A1 (en) * 1994-01-11 1995-07-13 N.V. Nutricia Method of treating disorders of the animal or human body by administering amino acids

Also Published As

Publication number Publication date
AU2089297A (en) 1998-10-12
WO1998041216A1 (en) 1998-09-24
JP2001514667A (en) 2001-09-11

Similar Documents

Publication Publication Date Title
GB9704524D0 (en) Composition
GB9702238D0 (en) Compositions
GB9715203D0 (en) Composition
PL340305A1 (en) Composition of agents reducing the level of lipoides
GB9713620D0 (en) Composition
HK1027508A1 (en) Composition for prevention of hepatic steatosis.
GB9711683D0 (en) Composition
GB9715489D0 (en) Composition
GB9714010D0 (en) Composition
GB9726777D0 (en) Composition
EP0958806A4 (en) Haircoloring composition
GB9714359D0 (en) Composition
GB9701031D0 (en) Composition
GB9726284D0 (en) Composition
AUPO371096A0 (en) Corrosion inhibiting composition
GB9826467D0 (en) Composition
GB9724975D0 (en) Composition
GB9703109D0 (en) Compositions
GB9705110D0 (en) Composition
GB9819176D0 (en) Steel composition
EG23068A (en) Pesticidale composition
LT97189A (en) Composition for aperitive
GB9715024D0 (en) Primer composition
GB9718910D0 (en) Composition
GB9726205D0 (en) Composition

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20090317